Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Symbicort Single Inhaler Therapy vs Conventional Best Practice in Persistent Asthma
NCT00238784Phase 3Completed
- Sponsor
- AstraZeneca
- Start
- May 2004
- Primary completion
- Oct 2005
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 3 trial of budesonide in asthma, sponsored by AstraZeneca. Started May 2004; status: completed.
02
Drugs
budesonide
03
Conditions
asthma
Beyond the preview
Go deeper on NCT00238784.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00238784.